Inventor · disambiguated record
William Van Osdol
Also filed as: OSDOL WILLIAM W VAN · VAN OSDOL WILLIAM · VAN OSDOL WILLIAM W · VAN OSDOL WILLIAM WOODSON
7 granted patents·31 pending applications·33 citations·filing 1998–2022
83Inventor score
Top patents by PatentIndex Score
38 records- 0189US9616055B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2015·Granted Apr 11, 2017·7 cites·17 claims
- 0284US9884056B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2017·Granted Feb 6, 2018·3 cites·16 claims
- 0383US10328068B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2017·Granted Jun 25, 2019·2 cites·20 claims
- 0478US6960353B2Formulations for the transdermal administration of fenoldopamALZA CORP·Filed 2003·Granted Nov 1, 2005·7 cites·42 claims
- 0575US2023165964A1Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the SameDURECT CORP·Filed 2022·Application pending·0 cites
- 0674US2021113541A1Transdermal administration of fentanyl and analogs thereofALZA CORP·Filed 2020·Application pending·0 cites
- 0774US2021322517A1Biodegradable drug delivery compositionDURECT CORP·Filed 2021·Application pending·0 cites
- 0872US2020289488A1Transdermal administration of fentanyl and analogs thereofALZA CORP·Filed 2020·Application pending·0 cites
- 0971US2019209654A1Biodegradable Drug Delivery CompositionDURECT CORP·Filed 2018·Application pending·0 cites
- 1071US2021128598A1Radiation-Sterilized Biodegradable Drug Delivery CompositionsDURECT CORP·Filed 2020·Application pending·0 cites
- 1170US2020054619A1Transdermal administration of fentanyl and analogs thereofALZA CORP·Filed 2019·Application pending·0 cites
- 1268US11529420B2Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the sameDURECT CORP·Filed 2020·Granted Dec 20, 2022·0 cites·10 claims
- 1368US2010260844A1Oral pharmaceutical dosage formsSCICINSKI JAN J·Filed 2009·Application pending·0 cites
- 1468US2019167655A1Transdermal Administration Of Fentanyl And Analogs ThereofALZA CORP·Filed 2019·Application pending·0 cites
- 1567US2019070206A1Radiation - Sterilized Biodegradable Drug Delivery CompositionsDURECT CORP·Filed 2018·Application pending·0 cites
- 1666US10758623B2Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the sameDURECT CORP·Filed 2018·Granted Sep 1, 2020·0 cites·16 claims
- 1766US2013259907A1Biodegradable Drug Delivery CompositionDURECT CORP·Filed 2013·Application pending·0 cites
- 1866US2020000791A1Oral pharmaceutical dosage formsDURECT CORP·Filed 2019·Application pending·0 cites
- 1965US2018098979A1Transdermal administration of fentanyl and analogs thereofALZA CORP·Filed 2017·Application pending·0 cites
- 2065US2014271799A1Transdermal administration of fentanyl and analogs thereofALZA CORP·Filed 2014·Application pending·0 cites
- 2165US2017189547A1Biodegradable Drug Delivery CompositionDURECT CORP·Filed 2016·Application pending·0 cites
- 2264US2009004257A1Transdermal administration of fentanyl and analogs thereofVENKATRAMAN SUBRAMANIAN S·Filed 2008·Application pending·0 cites
- 2363US2014030316A1Transdermal administration of fentanyl and analogs thereofALZA CORP·Filed 2013·Application pending·0 cites
- 2462US2012225033A1Biodegradable Drug Delivery CompositionVAN OSDOL WILLIAM W·Filed 2011·Application pending·0 cites
- 2562US2017196989A1Radiation-sterilized biodegradable drug delivery compositionsDURECT CORP·Filed 2016·Application pending·0 cites
- 2661US2014193365A1Biodegradable Drug Delivery CompositionDURECT CORP·Filed 2013·Application pending·0 cites
- 2761US2016331740A1Transdermal administration of fentanyl and analogs thereofALZA CORP·Filed 2016·Application pending·0 cites
- 2861US2014011842A1Oral Pharmaceutical Dosage FormsDURECT CORP·Filed 2013·Application pending·0 cites
- 2959US2016303242A1Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the SameDURECT CORP·Filed 2014·Application pending·0 cites
- 3058US2014294977A1Radiation-Sterilized Biodegradable Drug Delivery CompositionDURECT CORP·Filed 2012·Application pending·0 cites
- 3157US2004213832A1Transdermal administration of fentanyl and analogs thereofVENKATRAMAN SUBRAMANIAN S·Filed 2004·Application pending·0 cites
- 3254US6699497B1Formulations for the transdermal administration of fenoldopamALZA CORP·Filed 1999·Granted Mar 2, 2004·14 cites·34 claims
- 3351US2004258742A1Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidinesFiled 2004·Application pending·0 cites
- 3451US2003026829A1Transdermal administration of fentanyl and analogs thereofFiled 2002·Application pending·0 cites
- 3550US2004220785A1Computational model for transdermal drug deliveryFiled 2004·Application pending·0 cites
- 3647US2005208117A1Transdermal administration of fentanyl and analogs thereofVENKATRAMAN SUBRAMANIAN S·Filed 2005·Application pending·0 cites
- 3747US2003198662A1Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidinesFiled 2003·Application pending·0 cites
- 3827US2001051181A1Novel formulations for the transdermal administration of asimadolineFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Van Osdol files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →